title: [Lisinopril effects on cerebral blood flow and blood rheology in hypertensive patients].
abstract: OBJECTIVE
  To access the effect of lisinopril (diroton) on cerebral circulation and blood rheology in patients with arterial hypertension stage II.
  
  
  METHODS
  The trial included 37 patients (16 males, 21 females) with a mean arterial hypertension (AH) history 15.9 +/- 5.6 years. Diroton was given in a dose 10-40 mg/day for 6 months. Cerebral circulation (total cerebral circulation and venous outflow--TCC and VOF) was accessed by means of doppler ultrasonography. Blood and plasm rheology was determined using a rotational viscozymeter ACP-2. Instrumental tests were performed at baseline and at the end of the study.
  
  
  RESULTS
  Rheology tests showed that diroton-treated patients achieved a significant decrease in blood viscosity in high, moderate and low shear stress and plasma viscosity, a decrease in platelet aggregation index and an increase in the index of erythrocytic deformability. All these changes were accompanied with a significant fall in fibrinogen and hematocrit. Doppler ultrasound revealed an insignificant increase in TCC and VOF.
  
  
  CONCLUSIONS
  Diroton significantly improved impaired blood rheology and viscosity in AH patients as well as cerebral hemodynamics in patients with subnormal cerebral circulation and venous outflow at baseline.
authors.forename: L I
authors.initials: LI
authors.lastname: Markova
authors.forename: I V
authors.initials: IV
authors.lastname: Kuznetsova
authors.forename: A E
authors.initials: AE
authors.lastname: Radzevich
mesh_terms: D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D001809:Blood Viscosity / Q000187:drug effects*; D002560:Cerebrovascular Circulation / Q000187:drug effects* / Q000502:physiology; D004903:Erythrocyte Aggregation / Q000187:drug effects* / Q000502:physiology; D004907:Erythrocyte Deformability / Q000187:drug effects / Q000502:physiology; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006400:Hematocrit; D018056:Hemorheology; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D017706:Lisinopril / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D018608:Ultrasonography, Doppler
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D005340:Fibrinogen; D017706:Lisinopril